Pharmacokinetics of Norelgestromin and Ethinyl Estradiol Delivered by a Contraceptive Patch (Ortho Evra™/Evra™) under Conditions of Heat, Humidity, and Exercise
Open Access
- 1 December 2001
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 41 (12) , 1301-1309
Abstract
The objectives of this randomized, open‐label, three‐period, incomplete block design study were to evaluate the pharmacokinetics of norelgestromin (NGMN) and ethinyl estradiol (EE) delivered by the contraceptive patch, Ortho EvraTM/EvraTM, and to evaluate patch adhesion under conditions of heat, humidity, and exercise. During each treatment period, 30 healthy women wore Ortho EvraTM on the abdomen for 7 days under one of six conditions (normal activity, sauna, whirlpool, treadmill, cool water immersion, ora combination of activities). Blood samples were collected before and several times to 240 hours after patch application. Mean serum concentrations of NGMN and EE generally remained within the reference ranges, 0.6 to 1.2 ng/ml and 25 to 75 pg/ml, respectively, duringthe 7‐day wear period for all activities. Only 1 (1.1%) of 87 patches completely detached spontaneously. Peel force measurements were comparable for all activities. Ortho EvraTM was well tolerated. In conclusion, Ortho EvraTM delivers efficacious concentrations of NGMN and EE and maintains adhesive reliability through 7 days of wear even under conditions of heat, humidity, and exercise.Keywords
This publication has 16 references indexed in Scilit:
- Evaluation of Contraceptive Efficacy and Cycle Control of a Transdermal Contraceptive Patch vs an Oral ContraceptiveA Randomized Controlled TrialJAMA, 2001
- Comparison of efficacy, cycle control, compliance, and safety in users of a contraceptive patch vs an oral contraceptiveInternational Journal of Gynecology & Obstetrics, 2000
- Heat Exposure and DrugsClinical Pharmacokinetics, 1998
- Comparison of the local tolerability and adhesion of a new matrix system (Menorest®) for estradiol delivery with an established transdermal membrane system (Estraderm TTS®)Maturitas, 1997
- Comparison of two estradiol transdermal systems (Oesclim® 50 and Estraderm TTS® 50). I. Tolerability, adhesion and efficacyMaturitas, 1996
- Influences of Bathing and Hot Weather on the Pharmacokinetics of a New Transdermal Clonidine, M‐5041TThe Journal of Clinical Pharmacology, 1996
- Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine*Clinical Pharmacology & Therapeutics, 1996
- Use and misuse of oral contraceptives: Risk indicators for poor pill taking and discontinuationContraception, 1995
- Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimateAmerican Journal of Obstetrics and Gynecology, 1994
- Increased uptake of transdermal glyceryl trinitrate during physical exercise and during high ambient temperatureAmerican Heart Journal, 1986